Industry Payments During the COVID-19 Pandemic to Cardiologists in the United States
Anju Murayama, Sae Kamamoto, Haruki Shigeta, Akihiko Ozaki
Abstract
< 0.001) in the number of payments right after the COVID-19 pandemic onset, respectively. Cardiologists must consider the ethical implications of the potential for their clinical practice to be influenced by industry payments.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Confidence intervalPaymentPandemicHumanities2019-20 coronavirus outbreakPolitical scienceMedicineDemographyInternal medicineEconomicsPhilosophySociologyVirologyFinanceDiseaseInfectious disease (medical specialty)OutbreakPharmaceutical industry and healthcareHealthcare cost, quality, practicesPharmaceutical Economics and Policy